Article Text

Download PDFPDF
Double BCG vaccination in a neonate: implications, management and prevention
  1. Chinmay Chetan,
  2. Saikat Patra,
  3. Shailendra Kumar Singh and
  4. Girish Gupta
  1. Neonatology, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India
  1. Correspondence to Dr Girish Gupta; dscnnf{at}


Tuberculosis is a common cause of morbidity and mortality especially in low-income and middle-income countries like India. BCG vaccination is recommended for all neonates after birth in areas with a high tuberculosis disease burden. Here, we describe a case where a neonate received two doses of the BCG (Chennai strain) vaccine within a span of 4 days after birth due to a vaccination error. Parents were informed about the event. The infant was managed conservatively and followed up till 12 months of life for any possible complication. There were no serious adverse effects apart from the localised reaction and a double scar on the left arm. Measures to avoid any such error in the future and the need for reporting medication error has been highlighted. Parental concerns are frequent in such scenarios and should be actively addressed.

  • Paediatrics (drugs and medicines)
  • TB and other respiratory infections
  • Vaccination/immunisation
  • Neonatal health

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors The following authors were responsible for drafting of the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms, and critical revision for important intellectual content: CC, SP, SKS and GG. The following authors gave final approval of the manuscript: CC, SP, SKS and GG.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.